t-Darpp overexpression in HER2-positive breast cancer confers a survival advantage in lapatinib
Jessica L. Christenson(University of Colorado Anschutz Medical Campus), Susan E. Kane(Cell Signaling Technology (United States))
Cited by 22
Related Papers
A Method to Identify Serine Kinase Substrates
|Journal of Biological Chemistry|2002|534
Temporal Dynamics of Tyrosine Phosphorylation in Insulin Signaling
|Diabetes|2006|186
Darpp-32 and Its Truncated Variant t-Darpp Have Antagonistic Effects on Breast Cancer Cell Growth and Herceptin Resistance
|PLoS ONE|2009|57
Protein Kinase A Activation Confers Resistance to Trastuzumab in Human Breast Cancer Cell Lines
|Clinical Cancer Research|2009|53
Activity of Combined Androgen Receptor Antagonism and Cell Cycle Inhibition in Androgen Receptor Positive Triple Negative Breast Cancer
|Molecular Cancer Therapeutics|2021|51